Pharmacological stress diathesis syndromes

Journal of Psychopharmacology

Volumn 13, Issue 3, 1999, Pages 287-290

  Healy, David ^a   Tranter, Richard ^a  

^a Hergest Unit   (United Kingdom)

Author keywords

Addiction; Antidepressants; Dependence; Neuroleptics; Stress syndromes

Indexed keywords

ANTIDEPRESSANT AGENT; NEUROLEPTIC AGENT;

DISEASE PREDISPOSITION; DRUG DEPENDENCE; HUMAN; MENTAL STRESS; PERSONALITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; WITHDRAWAL SYNDROME;

EID: 0032831430     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988119901300312     Document Type: Review

References (23)

1. American Psychiatric Association (1990) Task force on benzodiazepine in dependence, benzodiazepine dependence, toxicity and abuse. APA, Washington DC
2. 2+ channels. Eur J Pharmacol 294: 459-467
3. Battegay R (1967) Drug dependence as a criterion for differentiation of psychotropic drugs. Compr Psychiatry 7: 501-509
4. Bury M, Gabe J (1991) Tranquillisers and health care in crisis. Soc Sci Med 32: 449-454
5. Coupland N J, Bell C J, Potokar J P (1996) Serotonin reuptake inhibitor withdrawal. J Clin Psychopharmacol 16: 356-362
6. Fink M (1998) Electrophysiology and psychopharmacology. In Ban T, Healy D, Shorter E (eds), The rise of psychopharmacology in the 1960s and the story of the CINP. Animula, Budapest
7. Fitzgerald K, Healy D (1995) Dystonias and dyskinesias of the jaw following the use of SSRIs. Hum Psychopharmacol 10: 215-220
8. Hollister L (1998) From hypertension to psychopharmacology. In Healy D (ed.), The psychopharmacologists II, pp. 215-235. Chapman & Hall, London
9. Kramer J C, Kline D F, Fink M (1961) Withdrawal symptoms following discontinuation of imipramine therapy. Am J Psychiatry 118: 549-550
10. Lane R M (1998) SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment. J Psychopharmacol 12: 192-213
11. Mann A M, MacPherson A S (1959) Clinical experience with imipramine (G22355) in the treatment of depression. Can Psychiatric Assoc J 4: 38-47
12. Medawar C (1997) The antidepressant web. Int J Risk Safety Med 10: 75-126
13. Nutt D J (1996) Addiction, brain mechanisms and their treatment implications. Lance 346:31-36
14. Oswald I, Lewis SA, Dunleavy D L F, Brezinova V, Briggs M (1971) Drugs of dependence though not of abuse: fenfluramine and imipramine. Brit Med J i: 70-73
15. Royal College of Psychiatrists/Royal College of General Practitioners (1992) MORI Poll reveals public confusion about antidepressives and tranquillisers. 'Antidepressants not addictive', say Defeat Depression Press Campaign. RCP/RCGP, London
16. Suppes T, Baldessarini R J, Motohashi N, Tondo L, Viguera A C (1997) Special treatment issues: maintaining and discontinuing psychotropic medications. In Rush A J (ed.), Mood disorders. Systematic medication management. Modern problems in pharmacopsychiatry. Basel, Karger 25: 235-254
17. Tranter B, Healy D (1998) Neuroleptic discontinuation syndromes. J Psychopharmacol 12: 306-312
18. Ulett G A, Holden J M C, Itil T M, Keskiner A (1969) A clinical and EEG study of withdrawal syndromes in schizophrenic patients. In Cerletti A, Bove F J (eds), The present status of psychotropic drugs. Excerpta Medica, Amsterdam
19. Viguera A C, Baldessarini R J, Hegarty J D, van Kammen D P, Tohen M (1997) Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment. Arch Gen Psychiatry 54: 49-55
20. Wegner J T, Struve F A, Kantor J S, Kane J M (1979) Relationship between the B-Mitten EEG pattern and tardive dyskinesia. Arch Gen Psychiatry 36: 599-603
21. WHO Expert Committee on Drug Dependence (1964) 13th Report, WHO Technical Report Series No. 273. World Health Organization, Geneva
22. WHO Expert Committee on Dependence Producing Drugs (1965) 14th Report, WHO Technical Report Series No. 312. World Health Organization, Geneva
23. WHO (1992) The International Classification of Diseases, ICD10. World Health Organization, Geneva